• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在脂肪性慢性丙型肝炎中,中央门静脉化与纤维化相关,但与非酒精性脂肪性肝炎的危险因素无关。

Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.

作者信息

Lee Hwajeong, Ainechi Sanaz, Dresser Karen, Kurian Elizabeth M

机构信息

Anatomic Pathology, Albany Medical College, 47 New Scotland Avenue, MC81, Albany, NY 12208, USA ; Anatomic Pathology, University of Massachusetts, 1 Innovation Drive, Biotech 3, Worcester, MA 01605, USA.

Anatomic Pathology, Albany Medical College, 47 New Scotland Avenue, MC81, Albany, NY 12208, USA.

出版信息

Int J Hepatol. 2014;2014:329297. doi: 10.1155/2014/329297. Epub 2014 Nov 30.

DOI:10.1155/2014/329297
PMID:25525520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4265703/
Abstract

Concomitant steatosis in chronic hepatitis C is associated with fibrosis and unfavorable treatment outcome. Central zone injury in nonalcoholic steatohepatitis (NASH) manifests as central portalization, with centrizonal microvessels and ductular reaction. We investigated whether central portalization in steatotic HCV biopsies would identify patients with metabolic risk factors for NASH. Liver biopsies with chronic hepatitis C and >10% steatosis (n = 65) were evaluated for the degree of steatosis, zonation of steatosis, fibrosis, and nonalcoholic fatty liver disease (NAFLD) activity score. The presence of centrizonal microvessels, sinusoidal capillarization, ductular reaction, and CK7 positive intermediate-phenotype hepatocytes were evaluated by CD34 and CK7 immunostain. The degree of steatosis and fibrosis showed a positive correlation. Additional positive correlations were noted between centrizonal angiogenesis and NAFLD activity score and central portalization and fibrosis. However, neither central portalization nor zonation of steatosis identified patients with metabolic risk factors for NASH. Therefore, central portalization cannot be used as a surrogate marker to identify patients with metabolic risk factors for NASH in steatotic HCV biopsies. The mechanism of centrizonal injury in steatotic HCV hepatitis is not solely attributable to the metabolic risk factors for NASH.

摘要

慢性丙型肝炎中的合并脂肪变性与纤维化及不良治疗结局相关。非酒精性脂肪性肝炎(NASH)中的中央区损伤表现为中央门静脉化,伴有中央区微血管和小胆管反应。我们研究了脂肪变性的丙型肝炎活检中的中央门静脉化是否能识别出具有NASH代谢危险因素的患者。对65例慢性丙型肝炎且脂肪变性>10%的肝活检组织进行脂肪变性程度、脂肪变性分区、纤维化及非酒精性脂肪性肝病(NAFLD)活动评分评估。通过CD34和CK7免疫染色评估中央区微血管、窦状隙毛细血管化、小胆管反应及CK7阳性中间型肝细胞的存在情况。脂肪变性程度与纤维化呈正相关。中央区血管生成与NAFLD活动评分以及中央门静脉化与纤维化之间也存在额外的正相关。然而,中央门静脉化和脂肪变性分区均未识别出具有NASH代谢危险因素的患者。因此,在脂肪变性的丙型肝炎活检中,中央门静脉化不能用作识别具有NASH代谢危险因素患者的替代标志物。脂肪变性的丙型肝炎肝炎中中央区损伤的机制并非完全归因于NASH的代谢危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc57/4265703/dbe83d086dbd/IJH2014-329297.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc57/4265703/dbe83d086dbd/IJH2014-329297.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc57/4265703/dbe83d086dbd/IJH2014-329297.001.jpg

相似文献

1
Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.在脂肪性慢性丙型肝炎中,中央门静脉化与纤维化相关,但与非酒精性脂肪性肝炎的危险因素无关。
Int J Hepatol. 2014;2014:329297. doi: 10.1155/2014/329297. Epub 2014 Nov 30.
2
Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的中央静脉动脉和微血管。
Am J Surg Pathol. 2011 Sep;35(9):1400-4. doi: 10.1097/PAS.0b013e3182254283.
3
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝活检中门静脉炎症、门脉浆细胞、界面肝炎和胆管损伤的流行情况及其临床意义。
Pathology. 2022 Oct;54(6):686-693. doi: 10.1016/j.pathol.2022.01.009. Epub 2022 May 5.
4
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.血清细胞角蛋白-18及其与非酒精性脂肪性肝病和丙型肝炎病毒患者通过FibroScan诊断的肝纤维化及受控衰减参数测定的肝脂肪变性的关系。
Eur J Gastroenterol Hepatol. 2019 May;31(5):633-641. doi: 10.1097/MEG.0000000000001385.
5
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型:脂肪性肝炎相关肝细胞癌。
Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.
6
Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.丙型肝炎病毒1型感染中血清脂联素水平与肝脂肪变性的相关性
Adv Ther. 2007 Sep-Oct;24(5):972-82. doi: 10.1007/BF02877701.
7
Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.慢性丙型肝炎患者中非酒精性脂肪性肝炎存在的相关因素。
Am J Gastroenterol. 2005 May;100(5):1091-8. doi: 10.1111/j.1572-0241.2005.41059.x.
8
Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease.慢性肝静脉流出道梗阻中的异常中央区特征:以门脉为基础病变的中央小叶模拟。
Am J Surg Pathol. 2014 Feb;38(2):205-14. doi: 10.1097/PAS.0000000000000099.
9
Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients.
Pol J Pathol. 2018;69(4):388-394. doi: 10.5114/pjp.2018.78517.
10
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.

引用本文的文献

1
Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.一般人群中特发性非肝硬化性门静脉高压的组织学特征的流行情况:偶然肝活检的回顾性研究。
Hepatol Int. 2017 Sep;11(5):452-460. doi: 10.1007/s12072-017-9801-6. Epub 2017 Jun 8.
2
In hepatic venous outflow obstruction, alcoholic liver disease, and nonalcoholic fatty liver disease, centrilobular scars, CD34+ vessels, and keratin 7+ hepatocytes are in close proximity.在肝静脉流出道梗阻、酒精性肝病和非酒精性脂肪性肝病中,中央小叶瘢痕、CD34+血管和角蛋白7+肝细胞紧密相邻。
Virchows Arch. 2017 Apr;470(4):411-420. doi: 10.1007/s00428-017-2074-6. Epub 2017 Jan 23.

本文引用的文献

1
Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease.慢性肝静脉流出道梗阻中的异常中央区特征:以门脉为基础病变的中央小叶模拟。
Am J Surg Pathol. 2014 Feb;38(2):205-14. doi: 10.1097/PAS.0000000000000099.
2
Metabolic syndrome and hepatitis C infection--brothers in arms.
Liver Int. 2013 Sep;33(8):1135-7. doi: 10.1111/liv.12234. Epub 2013 Jun 19.
3
Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study.肝小叶中央区肝细胞 CK7 表达异常:一项临床病理研究。
Histopathology. 2012 Nov;61(5):857-62. doi: 10.1111/j.1365-2559.2012.04278.x. Epub 2012 Jun 20.
4
2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.2011 年欧洲肝脏研究学会丙型肝炎病毒临床实践指南。
Liver Int. 2012 Feb;32 Suppl 1:2-8. doi: 10.1111/j.1478-3231.2011.02703.x.
5
Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的中央静脉动脉和微血管。
Am J Surg Pathol. 2011 Sep;35(9):1400-4. doi: 10.1097/PAS.0b013e3182254283.
6
Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered.肝内胆管反应中的胆管板。假说与意义。一、重新考虑胆管反应的类型。
Virchows Arch. 2011 Mar;458(3):251-9. doi: 10.1007/s00428-011-1048-3. Epub 2011 Feb 2.
7
Association between liver steatosis and angiogenesis in chronic hepatitis C.慢性丙型肝炎中肝脂肪变性与血管生成之间的关联
Pol J Pathol. 2010;61(3):154-60.
8
Hepatic steatosis and hepatitis C: Still unhappy bedfellows?肝脂肪变性与丙型肝炎:依然是不愉快的“同床者”吗?
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:96-101. doi: 10.1111/j.1440-1746.2010.06542.x.
9
Aberrant expression of cytokeratin 7 in perivenular hepatocytes correlates with a cholestatic chemistry profile in patients with heart failure.在心力衰竭患者中,围绕在肝血窦周围的肝细胞中细胞角蛋白 7 的异常表达与胆汁淤积性生化特征相关。
Mod Pathol. 2010 Dec;23(12):1650-6. doi: 10.1038/modpathol.2010.175. Epub 2010 Sep 3.
10
Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?脂肪变性和脂肪性肝炎是否会影响接受聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎感染患者的持续病毒学应答 (SVR) 率?
J Med Virol. 2010 May;82(6):958-64. doi: 10.1002/jmv.21744.